VCardio Healthcare — Advancing Better Healthcare Partnershipsjvhealthcare0123@gmail.com   |   +91 9876611336
VCardio Product

JEMPAGLIP-25

JEMPAGLIP-25 contains Empagliflozin 25 mg, an SGLT2 inhibitor used in type 2 diabetes and selected cardiovascular or kidney-related indications.

Product Information

JEMPAGLIP-25

CompositionEmpagliflozin 25 mg
Product TypeTablet
Packaging10 × 10 Blister
MRP₹1,200
Product CodeVH-20
DivisionVCardio Healthcare
Enquire About Product →
Detailed Information

Product Details

Information entered in the Product Information panel is displayed here automatically.

Uses & Benefits

Helps lower blood glucose
Promotes urinary glucose excretion
May provide cardiovascular benefits in appropriate patients
May provide kidney-related benefits in selected patients

Indications

Type 2 diabetes mellitus and selected heart-failure or chronic kidney disease indications according to the physician's assessment and applicable prescribing guidance.

Dosage / How to Use

Take exactly as prescribed. Maintain adequate hydration and follow the prescribed diabetes-management plan.

Side Effects

Increased urination, genital fungal infections, urinary infections, dehydration and low blood pressure may occur.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Prescription / Warning

Prescription medicine. Seek medical attention for severe dehydration or symptoms suggestive of ketoacidosis.
VCardio Healthcare

Need product information or a business enquiry?

Contact the VCardio Healthcare team for product, distribution and partnership enquiries.

Contact Us →